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ABSTRACT
The development of new methods for the preparation of chiral alcohols is vital
due to the presence of alcohols in natural products, pharmaceuticals, and a variety of
synthetic materials, as well as their versatility as synthetic intermediates.  Until recently,
oxidative kinetic resolution has been a relatively underdeveloped strategy for obtaining
enantioenriched alcohols.
The development of a palladium-catalyzed aerobic system for the enantioselective
oxidation of secondary alcohols is described.  This mild method utilizes (–)-sparteine as a
chiral ligand to resolve a wide range of benzylic, allylic, and cyclopropylcarbinyl
alcohols to high enantiomeric excesses with excellent selectivity.  The resolution of
pharmaceutical intermediates and the Claisen rearrangement of resolved allylic alcohols
demonstrate the utility of the method.
Mechanistic insights have driven further catalyst development.  Anionic ligand
modification has provided more efficient catalysts for the resolution of a broader array of
substrates.  Neutral ligand studies have led to an enantioselective alcohol oxidation
system with a diamine pseudo-enantiomeric to (–)-sparteine, allowing access to
enantioenriched alcohols in either enantiomeric series.
This methodology has been applied to the enantioselective total synthesis of (–)-
amurensinine via a selective C–H insertion, an aryne C–C insertion, and an oxidative
kinetic resolution with (–)-sparteine.  Use of an alternative diamine in the resolution
results in a formal synthesis of (+)-amurensinine.
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